Active substanceGamma-aminobutyric acidGamma-aminobutyric acid
Similar drugsTo uncover
  • Aminalon
    pills inwards 
    AKRIKHIN HFK, JSC     Russia
  • Aminalon
    pills inwards 
    ORGANICS, JSC     Russia
  • Aminalon
    pills inwards 
  • Dosage form: & nbspfilm-coated tablets
    Composition:

    In 1 tablet of the drug contains active substance: gamma-aminobutyric acid 250,000 mg, Excipients: sucrose (white sugar) - 27,200 mg, magnesium stearate - 2,800 mg, sheath: opadray 200 white (polyvinyl alcohol - 4,900 mg, titanium dioxide 3,500 mg, macrogol (polyethylene glycol) 1,680 mg, talc 3,343 mg, methacrylic acid copolymer type C 0.560 mg, sodium bicarbonate 0.017 mg) 14,000 mg.

    Description:Round biconvex tablets covered with a film coat of white or almost white color. On the cross section, the nucleus is white or almost white in color.
    Pharmacotherapeutic group:Nootropic remedy
    ATX: & nbsp

    N.03.A.G.03   Gamma-aminobutyric acid

    Pharmacodynamics:

    The nootropic agent improves the processes of metabolism of the brain tissues, facilitates the utilization of glucose by the brain and the removal of toxic metabolic products from it. It increases the productivity of thinking, improves memory, has a moderate psychostimulating effect, favorably affects the recovery of movements and speech after cerebral circulation disorders.Has a mild hypotensive effect, reduces initially high blood pressure (BP) and severity of hypertension-related symptoms (dizziness, sleeplessness ta), slightly reduces the heart rate. Has moderate antihypoxic and anticonvulsant action. In patients with diabetes mellitus, it reduces the glucose content, with a normal glucose content in the blood has the opposite effect (due to glycogenolysis).

    Pharmacokinetics:

    Absorption is fast, fairly complete. The time to reach the maximum concentration in blood plasma is 60 minutes, then the concentration rapidly decreases and after 24 hours it is not determined.

    Indications:

    Residual phenomena of craniocerebral trauma, stroke; cerebrovascular insufficiency, encephalopathy of various genesis, alcoholic encephalopathy, alcoholic polyneuropathy, cerebral palsy, the consequences of craniocerebral trauma in children older than 3 years, mental retardation, a symptomatic complex of motion sickness (sea and air sickness).

    Contraindications:Hypersensitivity to the components of the drug, children under 3 years old, acute renal failure, a deficiency of sugar / isomaltase,intolerance to fructose, glucose-galactose malabsorption, celiac disease.
    Carefully:Contraindicated in the 1st trimester of pregnancy and lactation. The use in the II and III trimester of pregnancy is possible on the prescription of the attending physician.
    Dosing and Administration:

    Inside, before eating. The daily intake for adults is 3-3.75 g; for children 4-6 years - 2-3 g / day, over 7 years - 3 g / day. The daily dose is divided into 3 divided doses. Treatment is carried out for a long time (from 2-3 weeks to 2-4 months); With residual effects of craniocerebral trauma, stroke, cerebrovascular insufficiency and encephalopathy of different genesis, depending on the nature and severity of the disease, 0.25-0.5-1.0 g 3 times a day for 1-3 months is prescribed.

    With alcoholic encephalopathy and polyneuropathy, the dose and duration of treatment is setindividually.

    With the consequences of craniocerebral trauma and mental retardation in children, aminalon is prescribed in high doses (2-3 g / day) for 2-3 months.

    For the purpose of prevention and treatment of adult motion sickness syndrome - 0.5 g, children - 0.25 g immediately before using vehicles, or 3 times a day for 3-4 days.

    Precautions for use

    If any of the possible side effects indicated in the manual are aggravated or if you notice any other side effects not listed in the instructions, tell your doctor.

    Side effects:Nausea, vomiting, insomnia, AD lability, dyspepsia, hyperthermia, dose-dependent side effects are amplified, allergic reactions can develop.
    Overdose:

    In case of an overdose, dozozavisimye side effects are intensified, tk. allergic reactions described in the section "Possible side effects with the use of the drug" are of a dose-independent nature.

    Treatment: gastric lavage, reception of activated charcoal, symptomatic therapy.

    Interaction:Strengthens the action of benzodiazepines, many hypnotic and antiepileptic drugs.
    Special instructions:In the first days of treatment, fluctuations in blood pressure (BP) are possible.
    Effect on the ability to drive transp. cf. and fur:AT the period of treatment should be careful when driving vehicles and refrain from engaging in potentially dangerous activities that require increased concentration and speed of psychomotor reactions.
    Form release / dosage:
    Tablets, film-coated, 250 mg.
    Packaging:

    10 tablets per contour cell pack.

    For 100 tablets in a can of light-protective glass or a can of polymer.

    The bank or 5 or 10 contour mesh packages together with the instruction for medical use are placed in a pack of cardboard box.

    Storage conditions:

    In the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.
    Shelf life:

    3 years. Do not use the product after the expiry date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LS-002236
    Date of registration:27.09.2011 / 16.11.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:ORGANICS, JSC ORGANICS, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp07.08.2017
    Illustrated instructions
      Instructions
      Up